AKT1 and hepatocellular carcinoma: In summary, the mouse and human studies suggest that TSC/mTORC1 is the main effector downstream of mTORC2/AKT1 in c-MYC–driven HCC and that loss of TSC accelerates c-MYC–induced liver tumor formation.